Phagos, a French biotech firm, has secured €25 million in Series A funding to deploy its AI-driven p...
Phagos, a French biotech firm, has secured €25 million in Series A funding to deploy its AI-driven phage therapy against antibiotic-resistant bacteria. The company's patented AI analyzes phage and bac...